Glaukos Corporation

As of June 30, 2026, Glaukos Corp carries a market capitalization of 7.24B, placing it among publicly traded companies globally. Its enterprise value stands at 7.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Glaukos Corp's next confirmed earnings release is scheduled for October 28, 2026.

As of June 30, 2026, Glaukos Corp has 58.86M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 13.28, and the price-to-book ratio stands at 12.12.

These figures are as of June 30, 2026. The EV/Sales ratio of 13.20 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 7.08B versus a market cap of 7.24B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Glaukos Corp maintains a current ratio of 5.04, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.07, indicating elevated leverage, while an interest coverage ratio of -29.95 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Glaukos Corp posted a negative return on equity (ROE) of -25.98, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -19.72, reflecting losses generated across the asset base. The company generates approximately 501,676.85 in revenue per employee across its workforce of 1,069.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.89 indicates how many times Glaukos Corp sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Glaukos Corp recorded an income tax benefit of -4.19M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -168.79M and -164.60M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Glaukos Corp's stock has gained approximately 137.59% over the past 52 weeks. The 50-day moving average sits at 150.24, while the 200-day moving average is 120.71.

Over the twelve months ended June 30, 2026, Glaukos Corp generated 536.42M in revenue and converted that into -164.60M in net income, yielding earnings per share of -2.84. EBITDA reached -128.60M, while operating income came in at -167.93M.

As of June 30, 2026, Glaukos Corp holds 250.53M in cash and equivalents against 90.01M in total debt, resulting in a net debt position of -100.21M. Total book value stands at 597.38M, with working capital of 361.89M providing operational flexibility.

Glaukos Corp produced -831,535.00 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -24.38M in capital expenditures, free cash flow totaled -25.21M - equivalent to -0.44 per share.

Over the twelve months ended June 30, 2026, Glaukos Corp posted a gross margin of 60.70, reflecting its pricing power and cost economics. The operating margin of -31.31 and net profit margin of -30.68 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -0.35: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.30, meaning Glaukos Corp raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Glaukos Corp has an Altman Z-Score of 19.63, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.